- $234.44bn
- $255.57bn
- $46.66bn
- 91
- 45
- 80
- 83
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 48,624 | 49,898 | 43,974 | 43,375 | 46,660 |
Cost of Revenue | |||||
Gross Profit | 34,694 | 35,498 | 32,583 | 32,164 | 34,640 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 39,538 | 39,746 | 33,982 | 35,566 | 37,085 |
Operating Profit | 9,086 | 10,152 | 9,992 | 7,809 | 9,575 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8,940 | 9,878 | 24,530 | 7,177 | 9,123 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7,147 | 8,071 | 22,905 | 6,049 | 8,572 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 11,732 | 8,072 | 24,021 | 6,955 | 14,850 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11,732 | 8,072 | 24,021 | 6,955 | 14,850 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.87 | 4.41 | 10.6 | 3.59 | 5.45 |
Dividends per Share |